[{"address1": "2450 Holcombe Blvd", "address2": "MS: BCM251", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "713 400 6400", "website": "https://markertherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Its multi tumor associated antigen-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens. The company also develops MT-401-OTS for the treatment of acute myeloid leukemia AND myelodysplastic syndromes; and MT-601 to treat lymphoma and pancreatic cancer. Marker Therapeutics, Inc. is headquartered in Houston, Texas.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Dr. Juan F. Vera M.D.", "age": 44, "title": "Co-Founder, CEO, President, Treasurer, Secretary & Director", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 400000, "exercisedValue": 0, "unexercisedValue": 9390}, {"maxAge": 1, "name": "Ms. Elizabeth  Donnelly", "title": "Director of Administration", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Maria-Bernadette  Madel Ph.D.", "age": 34, "title": "Director of Corporate Operations & External Communications", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edmund  Cheung", "title": "Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Patricia  Allison", "title": "Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Newman Ph.D.", "age": 65, "title": "Head of Regulatory Affairs", "yearBorn": 1959, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert Z. Florkiewicz Sr., Ph.D.", "title": "Senior Director of Molecular Biology & Virology", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.22, "open": 1.23, "dayLow": 1.19, "dayHigh": 1.26, "regularMarketPreviousClose": 1.22, "regularMarketOpen": 1.23, "regularMarketDayLow": 1.19, "regularMarketDayHigh": 1.26, "payoutRatio": 0.0, "beta": 1.375, "forwardPE": -0.84931505, "volume": 180791, "regularMarketVolume": 180791, "averageVolume": 281559, "averageVolume10days": 374600, "averageDailyVolume10Day": 374600, "bid": 1.21, "ask": 1.26, "bidSize": 1, "askSize": 2, "marketCap": 20674678, "fiftyTwoWeekLow": 0.81, "fiftyTwoWeekHigh": 5.95, "allTimeHigh": 6120000.0, "allTimeLow": 0.67, "priceToSalesTrailing12Months": 4.4035635, "fiftyDayAverage": 0.985, "twoHundredDayAverage": 1.2353, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 3084699, "profitMargins": 0.0, "floatShares": 13676466, "sharesOutstanding": 16673127, "sharesShort": 291574, "sharesShortPriorMonth": 285739, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0175, "heldPercentInsiders": 0.05493, "heldPercentInstitutions": 0.20703, "shortRatio": 1.76, "shortPercentOfFloat": 0.0424, "impliedSharesOutstanding": 16673127, "bookValue": 1.103, "priceToBook": 1.1242067, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -14298034, "trailingEps": -1.17, "forwardEps": -1.46, "lastSplitFactor": "1:10", "lastSplitDate": 1674777600, "enterpriseToRevenue": 0.657, "52WeekChange": -0.66483516, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 1.24, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.0, "targetMedianPrice": 6.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 17589978, "totalCashPerShare": 1.055, "totalDebt": 0, "quickRatio": 5.755, "currentRatio": 6.496, "totalRevenue": 4694988, "revenuePerShare": 0.368, "returnOnAssets": -0.55195, "returnOnEquity": -1.10672, "grossProfits": -9066857, "freeCashflow": -10881111, "operatingCashflow": -14817110, "revenueGrowth": -0.36, "grossMargins": -1.93118, "ebitdaMargins": 0.0, "operatingMargins": -1.73304, "financialCurrency": "USD", "symbol": "MRKR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Marker Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1026826200000, "postMarketChangePercent": 4.032254, "postMarketPrice": 1.29, "postMarketChange": 0.049999952, "regularMarketChange": 0.01999998, "regularMarketDayRange": "1.19 - 1.26", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 281559, "fiftyTwoWeekLowChange": 0.43, "fiftyTwoWeekLowChangePercent": 0.5308642, "fiftyTwoWeekRange": "0.81 - 5.95", "fiftyTwoWeekHighChange": -4.71, "fiftyTwoWeekHighChangePercent": -0.79159665, "fiftyTwoWeekChangePercent": -66.48351, "dividendDate": 1473984000, "earningsTimestampStart": 1754996340, "earningsTimestampEnd": 1755518400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.17, "epsForward": -1.46, "epsCurrentYear": -0.92, "priceEpsCurrentYear": -1.3478261, "fiftyDayAverageChange": 0.255, "fiftyDayAverageChangePercent": 0.25888324, "twoHundredDayAverageChange": 0.0047000647, "twoHundredDayAverageChangePercent": 0.0038047964, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1764367091, "regularMarketTime": 1764363600, "exchange": "NCM", "messageBoardId": "finmb_1725474", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "longName": "Marker Therapeutics, Inc.", "regularMarketChangePercent": 1.6393427, "regularMarketPrice": 1.24, "displayName": "Marker Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]